Home / CTSS Knockout Cell Lines

CTSS Knockout Cell Lines

Gene: CTSS

Official Full Name: cathepsin Sprovided by HGNC

Gene Summary: The preproprotein encoded by this gene, a member of the peptidase C1 family, is a lysosomal cysteine proteinase that participates in the degradation of antigenic proteins to peptides for presentation on MHC class II molecules. The mature protein cleaves the invariant chain of MHC class II molecules in endolysosomal compartments and enables the formation of antigen-MHC class II complexes and the proper display of extracellular antigenic peptides by MHC-II. The mature protein also functions as an elastase over a broad pH range. When secreted from cells, this protein can remodel components of the extracellular matrix such as elastin, collagen, and fibronectin. This gene is implicated in the pathology of many inflammatory and autoimmune diseases and, given its elastase activity, plays a significant role in some pulmonary diseases. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2020]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO38349 CTSS Knockout cell line (HeLa) Human CTSS 1:3~1:6 Negative Online Inquiry
KO38350 CTSS Knockout cell line (A549) Human CTSS 1:3~1:4 Negative Online Inquiry

Background

CTSS Gene Knockout Cell Lines are precisely engineered cellular models designed to study the role of the cathepsin S gene (CTSS) in various biological processes. These knockout cell lines are developed using CRISPR-Cas9 gene editing technology, which effectively disrupts the CTSS gene, resulting in cells that lack the expression of this specific protease. The unique mechanism of action involves the introduction of specific guide RNAs that direct the Cas9 nuclease to induce double-strand breaks at the target gene locus, leading to insertions or deletions that prevent the production of functional CTSS proteins.

The significance of CTSS in research and clinical settings is profound, given its involvement in essential biological processes such as antigen presentation, tissue remodeling, and immune response regulation. The absence of CTSS can illuminate pathways involved in various diseases, including cancer metastasis and autoimmune disorders, thus providing valuable insights that can lead to novel therapeutic strategies.

What sets our CTSS Gene Knockout Cell Lines apart from alternatives is the accuracy and efficiency of the CRISPR-Cas9 technology we employ, which minimizes off-target effects. Moreover, our cell lines come with extensive characterization data, ensuring reliability for experimental reproducibility. This specificity and validation make them indispensable tools for both basic and translational research, allowing scientists to delve deeper into the CTSS-related cellular mechanisms.

Researchers and clinicians benefit significantly from these knockout models, as they provide a unique opportunity to investigate the functional implications of CTSS loss in physiological and pathological contexts. In addition, by utilizing these models in drug development pipelines, users can identify potential targets for intervention and assess therapeutic efficacy more accurately.

Our company prides itself on years of expertise in creating high-quality biological research tools that accelerate scientific discovery. With a commitment to innovation and excellence, our CTSS Gene Knockout Cell Lines represent a crucial addition to the arsenals of researchers seeking to advance their work in molecular biology and disease modeling.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.